AngioLab Inc is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The Company manufactures and sells finished health functional food products using lemon balm extract mixed powder as the main ingredient, and health functional food raw materials such as lemon balm extract mixed powder. In addition, the Company develops pharmaceutical products and health functional foods based on angiogenesis inhibition.

Employees

Sector

Food Processing

More about the company

Quotes

Date	Price	Change	Volume
09/09/26	₩3,295.00	-0.15%	218
08/09/26	₩3,300.00	+3.12%	672
07/09/26	₩3,200.00	0.00%	871
04/09/26	₩3,200.00	+10.73%	1,852
03/09/26	₩2,890.00	-0.17%	2,087

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 09/09/2026			5-day change	1st Jan Change
3,295.00 ^KRW	-0.15%		+13.82%	+33.94%

29/11/21	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
16/11/21	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI

29/11/21	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
16/11/21	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
23/09/20	Hanyang Securities Co., Ltd., Investment Arm and Sun-Tae Kim acquired 2.9% stake in Angiolab, Inc. from KB 12-1 Venture Fund of KB Investment Co., Ltd. for KRW 1.2 billion.	CI
17/09/20	Angiolab, Inc. cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.	CI
28/06/20	Angiolab, Inc. signed a contract to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction for KRW 66.3 billion.	CI
18/07/19	Angiolab, Inc. announced that it has received KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd.	CI
27/06/19	Angiolab, Inc. announced that it expects to receive KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd. and another investor	CI
15/04/18	Angiolab, Inc. announced that it has received KRW 646.1616 million in funding from Yuanta Venture Capital Corp.	CI
08/10/14	Angiolab, Inc. announced that it has received KRW 1 billion in funding from Yuanta venture capital.	CI

1 day	-0.15%
1 week	+13.82%
Current month	+31.80%
1 month	+73.42%
3 months	+68.97%
6 months	+39.32%
Current year	+33.94%

1 week	2,870	3,400
1 month	1,660	3,500
Current year	1,523	3,500
1 year	1,523	4,635
3 years	1,523	9,200
5 years	1,523	12,250
10 years	1,523	25,800

Angiolab, Inc. Share Price

Stocks

A251280

KR7251280004

Food Processing

Chart: Angiolab, Inc.

Latest news : Angiolab, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Angiolab, Inc.

Special Foods & Wellbeing Products

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Min-Yeong Kim CEO	Chief Executive Officer	69	02/06/1999
Il-Hwan Jo PRN	Corporate Officer/Principal	65	-
Byeong-Yeong Park CTO	Chief Tech/Sci/R&D Officer	57	26/07/2016

Director	Title	Age	Since
Min-Yeong Kim BRD	Director/Board Member	69	02/06/1999
Byeong-Yeong Park BRD	Director/Board Member	57	26/07/2016
Il-Hwan Jo BRD	Director/Board Member	65	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ANGIOLAB, INC.	-0.15%	+13.82%	-14.08%	-60.77%	8.59M
ZHEJIANG NHU COMPANY LTD.	+1.24%	+1.24%	+9.41%	+66.24%	12.34B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-7.58%	-6.25%	-28.46%	+267.85%	8.66B
BYHEALTH CO., LTD	-0.71%	+0.10%	-20.73%	-48.09%	2.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-1.41%	+2.07%	-15.76%	-3.84%	1.53B
JAMIESON WELLNESS INC.	-0.09%	+0.18%	+23.01%	+77.28%	1.37B
HERBALIFE LTD.	-2.45%	+1.64%	+33.15%	-13.92%	1.32B
BELLRING BRANDS, INC.	+0.58%	-7.69%	-73.88%	-76.53%	1.1B
TSI GROUP CO., LTD.	-4.57%	-10.65%	-42.27%	-	1.07B
THE SIMPLY GOOD FOODS COMPANY	-2.69%	-11.27%	-62.45%	-69.12%	919M
Average	-1.79%	-1.06%	-19.21%	+15.45%	3.08B
Weighted average by Cap.	-2.09%	-1.77%	-10.19%	+99.46%

	2014	2015
Net sales	878M 1,177B 756M 712M 649M 1.21B 83.59B 1.22B 8.44B 3.26B 42.58B 3.3B 3.23B 135B	703M 942B 605M 569M 519M 971M 66.86B 974M 6.75B 2.61B 34.06B 2.64B 2.58B 108B
Net income	-350M -469B -301M -284M -259M -484M -33.33B -486M -3.36B -1.3B -16.98B -1.32B -1.29B -53.8B	-1.19B -1,590B -1.02B -961M -876M -1.64B -113B -1.65B -11.39B -4.4B -57.52B -4.46B -4.36B -182B
Net Debt	-	-